Table 5.
Overall frequency of atypical metastases and rate of atypical metastases based on primary location
| Primary site | Cases with atypical metastases n (% of cases with metastases) |
Cases with only atypical mets |
|||
| n | % of cases of that primary | % of cases of that primary with metastases | % of cases with only atypical metastases | ||
| Head/neck | 14/24 (58.3) | 4 | 4.5% | 16.7% | 19.0% |
| Back | 20/40 (50) | 5 | 4.4% | 12.5% | 23.8% |
| Lower extremity | 15/54 (27.8) | 6 | 5.8% | 11.1% | 28.6% |
| Anterior chest wall | 5/12 (41.7) | 2 | 6.1% | 16.7% | 9.5% |
| Ocular | 5/20 (25) | 0 | 0% | 0% | 0% |
| Upper extremity | 4/8 (50) | 1 | 3.4% | 12.5% | 4.8% |
| Pelvis | 2/5 (40) | 1 | 6.7% | 20% | 4.8% |
| Anorectal | 1/3 (33.3) | 0 | 0% | 0% | 0% |
| Sinonasal | 1/3 (33.3) | 0 | 0% | 0% | 0% |
| Anterior abdominal wall | 0/1 (0) | 0 | 0% | 0% | 0% |
| Labia/vagina | 0/1 (0) | 0 | 0% | 0% | 0% |
| Oral mucosa | 0/0 (0) | 0 | 0% | 0% | 0% |
| Enteric | 0/0 (0) | 0 | 0% | 0% | 0% |
| Unknown | 4/10 (40) | 2 | 13.3% | 20% | 0% |